Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas

Journal of Pathology

Volumn 192, Issue 2, 2000, Pages 194-202

  Xerri, Luc ^a,b   Palmerini, Fabienne ^a,b   Devilard, Elisabeth ^a,b   Defrance, Thierry ^b   Bouabdallah, Reda ^a   Hassoun, Jacques ^a   Birg, Franoise ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

Author keywords

Apoptosis; Caspase 3; Caspase 8; Hodgkin's disease; ICAD; Immunohistochemistry; Non Hodgkin's lymphoma; Subcellular fractionation

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE ACTIVATED DNASE INHIBITOR; DEOXYRIBONUCLEASE; ENZYME INHIBITOR; FAS ANTIGEN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL FRACTIONATION; CELL NUCLEUS; CYTOPLASM; ENZYME ACTIVATION; ENZYME LOCALIZATION; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LYMPHOID TISSUE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; T CELL LYMPHOMA;

B-LYMPHOCYTES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CASPASES; CELL NUCLEUS; CYTOPLASM; DEOXYRIBONUCLEASES; GERMINAL CENTER; HODGKIN DISEASE; HUMAN; LYMPHOMA, NON-HODGKIN; NEOPLASM PROTEINS; PROTEINS; REED-STERNBERG CELLS; SUPPORT, NON-U.S. GOV'T;

EID: 0033776614     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH685>3.0.CO;2-M     Document Type: Article

References (39)

1. Antigen receptor induced apoptosis of human germinal center B-cells is targeted to a centrocytic subset
2. A role for Fas in negative selection of thymocytes in vivo
3. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphomas
4. Resistance of cultured peripheral T-cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase-8) to the CD95 death inducing signalling complex
5. Malignant and reactive cells from human lymphomas frequently express the Fas ligand but display a different sensitivity to Fas-mediated apoptosis
6. Sensitivity to Fas-mediated apoptosis is null or weak in B-cell non-Hodgkin's lymphomas and is moderately increased by CD40 ligation
7. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis
8. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
9. Prodomains-adaptors-oligomerization: The pursuit of caspase activation in apoptosis
10. Deciphering the pathways of life and death
11. Caspases: Killer proteases
12. FADD, a novel death containing protein, interacts with the death domain of Fas and initiates apoptosis
13. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
14. FLICE is activated by association with the CD95 death-inducing signalling complex (DISC)
15. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex
16. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1b-converting enzyme
17. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
18. Apopain/ CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death
19. Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
20. Immunohistochemical detection and mapping of a cytokeratin 18 neo epitope exposed during early apoptosis
21. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
22. Inhibition of apoptosis-associated DNA fragmentation activity in non-apoptotic cells: The role of DNA fragmentation factor-45 (DFF45/ICAD)
23. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
24. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
25. Cleavage of DFF-45/ICAD by multiple caspases is essential for its function during apoptosis
26. FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis
27. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
28. Cytoplasmic retention, DNA binding and processing of the NF-κB p50 precursor are controlled by a small region in its C-terminus
29. Functional differences of two forms of the inhibitor of caspase-activated DNase, ICAD-L, and ICAD-S
30. Cysteine protease CPP32, but not Ich1-L, is expressed in germinal center B cells and their neoplastic counterparts
31. Immunolocalization of the ICE/ced-3 family protease CPP32 (caspase-3) in non-Hodgkin's lymphomas, chronic lymphocytic leukemias and reactive lymph nodes
32. Germinal centers
33. Activation of caspase-1 in the nucleus requires nuclear translocation of pro-caspase-1 mediated by its prodomain
34. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis
35. Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis
36. Targeted disruption of the mouse caspase-8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally
37. ICAD/DFF regulator of apoptotic nuclease is nuclear
38. Autoproteolytic activation of pro-caspases by oligomerization
39. Immunohistochemical analysis of interleukin-1 beta-converting enzyme/Ced-3 family protease, CPP32/Yama/caspase-3, in Hodgkin's disease